General ENT News

ENT

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Yu KH et al. – It was feasible to give IAC concurrent with accelerated fractionation radiotherapy for locally advanced HNSCC. The maximum tolerated dose of cisplatin was 125 mg/m2.

Related Articles

Spread of Squamous Cell Carcinoma From the Thumb to the Small Finger via the Flexor Tendon Sheaths
The Journal of Hand Surgery, 11/16/09    Relevance Score: 83%

Squamous cell cancer of the rectum
World Journal of Gastroenterology, 10/01/09    Relevance Score: 82%

Primary cutaneous myxoid spindle cell squamous cell carcinoma: a clinicopathologic study and review of the literature
Journal of Cutaneous Pathology, 10/09/09    Relevance Score: 81%

RalA suppresses early stages of Ras-induced squamous cell carcinoma progression
Oncogene, 10/08/09    Relevance Score: 81%

Nd:YAG laser therapy of carcinoma lip (stage I squamous cell carcinoma): a retrospective evaluation
Indian Journal of Otolaryngology and Head & Neck Surgery, 10/07/09    Relevance Score: 81%

Today in Head and Neck...keeping you current

Early Prediction of Response to Chemoradiotherapy for Head and Neck Cancer
Archives of Otolaryngology, 11/25/09

Complications of hydroxyapatite bone cement reconstruction of retrosigmoid craniotomy: Two cases
ENT Journal, 11/25/09

N2 Disease in Patients With Head and Neck Squamous Cell Cancer Treated With Chemoradiotherapy
Archives of Otolaryngology, 11/25/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address